Atara Biotherapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Thousand Oaks, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Atara Biotherapeutics, Inc. has filed 1,129 SEC EDGAR filings since 10 Apr 2014

SEC filing history

Showing 526-550 of 1,000 matching filings.

Per page
25
Current page
22
SC 13G File 005-88393

SCHEDULE 13G HOLDINGS REPORT

Filing date
01 Nov 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
30 Sep 2019
Reporting date
27 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88393

SC 13G/A filing

Filing date
12 Aug 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36548

8-K

Filing date
08 Aug 2019
Reporting date
08 Aug 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88393

PRIMARY DOCUMENT

Filing date
29 Jul 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36548

8-K

Filing date
22 Jul 2019
Reporting date
18 Jul 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-223262

424B5

Filing date
19 Jul 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-223262

424B5

Filing date
18 Jul 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Jul 2019
Reporting date
27 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Jul 2019
Reporting date
27 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Jul 2019
Reporting date
27 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Jul 2019
Reporting date
27 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Jul 2019
Reporting date
27 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Jul 2019
Reporting date
27 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36548

8-K

Filing date
28 Jun 2019
Reporting date
27 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
25 Jun 2019
Reporting date
24 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
25 Jun 2019
Reporting date
24 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36548

8-K

Filing date
05 Jun 2019
Reporting date
05 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
31 May 2019
Reporting date
29 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36548

8-K

Filing date
28 May 2019
Reporting date
23 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 May 2019
Reporting date
13 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36548

8-K

Filing date
09 May 2019
Reporting date
09 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .